Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

f the Arana Group is or may be otherwise entitled or to require repayment of any grant, development assistance or other financial assistance previously provided to any member of the Arana Group.

(ii) Specific instances

Without limiting paragraph (c)(i), the directors of Arana confirm in the Target's Statement that, as a result (directly or indirectly) of the acquisition or proposed acquisition of Arana Shares by Cephalon International, none of Centocor Inc., Abbott Laboratories Inc., Domantis Limited and any of their respective affiliates becomes entitled to exercise any right under any provision of an agreement with any member of the Arana Group, which right, upon its exercise, results or would result, or could reasonably be expected to result, in any such agreement or other instrument being terminated or varied or any other action being taken or arising under it.

(d) No prescribed occurrences

(i) Between the time beginning when the Bidder's Statement is given to Arana and ending at the end of the Offer Period, none of the following occurrences happens:

(A) Arana converts all or any of the Arana Shares into a larger or smaller number of Arana Shares;

(B) any member of the Arana Group resolves to reduce its share capital in any way;

(C) any member of the Arana Group enters into a buy-back agreement or resolves to approve the terms of a buy-back agreement under section 257C(1) or 257D(1) of the Corporations Act;

(D) any member of the Arana Group issues shares (other than pursuant to Performance Rights) or grants an option over its shares, or agrees to make such an issue or grant such an option;

(E) any member of the Arana Group issues, or agrees to issue, convertible notes;

(F) any member of the Arana Group disposes, or agrees to dispose, of the whole, or a substantial part, o
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... (PRWEB) December 26, 2014 It is said ... great dress. Today, UWDress.com, the famous wedding dress supplier, ... launches a site-wide cocktail gown promotion. , UWDress.com’s navy ... collection, and they come in high fashion styles. Simple dresses ... depending on the occasion; they are specially designed for those ...
(Date:12/26/2014)... 26, 2014 “Many people become overwhelmed ... injury claim issues and phone calls with insurance companies,” ... article featuring their free eBook on pedestrian and ... on pedestrian and bicycle auto accident claims assures the ... capable of professionally handling their case while they focus ...
(Date:12/25/2014)... 26, 2014 The microscopy market ... 7.2% to reach $5,756.0 million by 2019. Optical ... market. The electron microscopes product segment is expected ... period. , Rising focus on nanotechnology, technological advancements, ... the microscopy market. , Get Full Copy of ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... , FRIDAY, Jan. 14 (HealthDay News) -- Bacteria that prey ... say U.S. researchers. They tested two types of predatory ... -- on dozens of other bacteria. "They actually ... life cycles. They have a great ability to seek out ...
... , FRIDAY, Jan. 14 (HealthDay News) -- Remember the intensity ... years, the never-ending housework and the demands of raising a ... spouse? New research using brain scans suggests some married ... or more. When gazing at a photo of their ...
... Intensive early education programs for low-income children have been ... have looked more broadly at their impact on health ... at Columbia University,s Mailman School of Public Health examines ... Abecedarian Project (ABC), a randomized control study that enrolled ...
... FRIDAY, Jan. 14 (HealthDay News) -- Internal medicine residents ... care doctors, who are expected to be in greater ... study from Johns Hopkins. They,re unprepared to care ... hypertension and high cholesterol, the study says, though they ...
... E. coli uses a laser to detect and ... waterways. The technique described this month in the International ... the incidence of waterborne disease outbreaks. Microbial contamination of ... diseases are the leading causes of illness and death in ...
... blood pressure, according to new research by the University of ... or hypertension is one of the major cardiovascular ... costs more than $300 billion each year. Around a quarter ... million people in the UK and one in three US ...
Cached Medicine News:Health News:Predatory Bacteria May Help Control Antibiotic-Resistant Germs 2Health News:Brain Scans Show Married Love Can Last 2Health News:Brain Scans Show Married Love Can Last 3Health News:Enhanced early childhood education pays long-term dividends in better health 2Health News:Med School Grads May Not Be Ready for Primary Care 2Health News:Speeding up E. coli detection 2Health News:Bioactive compounds in berries can reduce high blood pressure 2
(Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
(Date:12/24/2014)... 23, 2014 Echo Therapeutics, Inc. (NASDAQ: ... focused on skin permeation, continuous glucose monitoring and ... Hollander has been appointed Chief Executive Officer ... than 20 years of experience in the medical ... recently served as Vice President, Business Development, Otsuka ...
(Date:12/24/2014)... , Dec. 23, 2014   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... Agency (EMA) of the Marketing Authorization Application (MAA) ... recently granted the company,s request for accelerated assessment, ... regulatory review time.   The MAA, ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... Penile Prosthesis (IPP) is a ... surgically implanted into the penis ... dysfunction (also known as impotence). ... with voluntary control over the ...
... Positionable Penile Prosthesis,The ... prosthesis is made of ... core strength that gives ... most: ease of positioning, ...
... AMS Ambicor is a uniquely designed two-piece ... cylinders implanted in the corpora cavernosa and ... scrotum. Patients simply squeeze the pump to ... the prosthesis. This closed, fluid-filled system allows ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: